Summary
Updated Aug 30, 2026
James M. Ahlers is Chief Financial Officer of Cue Biopharma, Inc. (CUE). 1 SEC Form 4 filing on record, dated 3 August 2026.
Recent Transactions
1Every recent SEC Form 4 transaction James M. Ahlers has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies James M. Ahlers files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.61M of CUE open-market activity in the last 12 months
- Sumita Ray - $266K of CUE open-market activity in the last 12 months
- Michael Vincent Meluzio - $169K of CUE open-market activity in the last 12 months
- Pasha Sarraf - $100K of CUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James M. Ahlers?
James M. Ahlers is a corporate insider, tracked as Chief Financial Officer of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James M. Ahlers submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of James M. Ahlers's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James M. Ahlers and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
